Aaron Pearce
Analyst · Baird. Your line is open
Thank you Michael and good morning everyone. I'll start the financial review on Slide number 3, this quarter revenues were down 1.2% to $286.8 million when compared to the third quarter of last year. This reduction consists of an organic sales decline of 0.1% and a reduction of 1.1% due to foreign currency translation. Turning to earnings, on a GAAP basis our EPS grew 27% this quarter. Diluted EPS was $0.42 in the quarter compared to GAAP EPS of $0.33 in the third quarter of last year. We have no non-GAAP items to call out this year. However, when comparing against the prior year earnings and EPS figures the best measure is prior year non-GAAP earnings from continuing operations as it excludes restructuring charges, discontinued operations and a one-time gain from a curtailment of a postretirement benefit plan. Non-GAAP EPS from continuing operations was $0.34 in last year's third quarter, which compares to our GAAP EPS of $0.42 in the current quarter, a solid increase of 23.5%. Slide number 4 is a summary of our quarterly sales trends. In the third quarter revenues finished at $286.8 million and as I just mentioned total company organic sales decreased by 0.1%. On a divisional basis, organic sales decreased by 0.8% in the Identification Solutions segment and increased by 1.2% in the Workplace Safety segment. Looking a bit deeper at our slight organic sales decline, we saw a declining sales in market such as Western Canada, Western Australia and parts of Texas and the Dakotas where our customer base and the economy in general has some times to natural resource extractions such as mining, natural gas or oil. At the same time we saw an improvement in geographies where there is less of tie to natural resources such as in Western Europe. This quarter we had benefited from an extra work day when compared to the prior year. This extra day won't repeat in the fourth quarter, in fact we will have one less work day in the fourth quarter of this year as compared to the fourth quarter of last year. We also experienced a slight slowdown in our order pattern in April after relative stability in February and March, neither our order patterns nor the number of work days sets up well for organic sales growth into the fourth quarter. Overall, foreign currency continues to be a bit of headwind when compared to the third quarter of last year, as evidenced by the 1.1% decline in sales attributed to foreign currency translation. However if we look at foreign currency on a sequential basis, the US Dollar depreciated this quarter versus a broad basket of currencies when compared to the second quarter of this fiscal year. To put this in perspective, coming into the quarter we anticipated an approximate 3% decline in sales during to foreign currency and we ended with 1.1% decline. Turning to Slide number 5, you can see that our third quarter gross profit margin finished at 50.7%. This represents a 210 basis point improvement over the third quarter of last year. More importantly, this continues the trend of sequential gross margin improvements up 120 basis points when compared to the second quarter of this fiscal year. Sequentially, we're seeing most of our gross profit margin improvement in the facilities that we consolidated in fiscal 2015. We're encouraged by these improvements but as Michael mentioned, we know that we have more work to do over the next several quarters and years in order to achieve our operational and efficiency goal. On the left-hand side of Slide number 6, is the trending of SG&A expense. SG&A expense was $105.8 million this quarter compared to $103 million in Q3 of last year. The prior year SG&A expense included a pre-tax gain of $4.3 million due to the curtailment of a postretirement medical plan. If you exclude the impact of this gain SG&A expense would have been down $1.5 million when compared in the third quarter of this year to the third quarter of last year. On the right-hand side of this page is the chart summarizing our general and administrative expenses. G&A expenses finished at $29.4 million in the third quarter compared to $24.8 million in last year's third quarter. Again if you adjust the prior year G&A expense for the curtailment gain I just mentioned, we see that G&A expense was effectively flat with the prior year. Moving onto Slide number 7, you can see that our diluted earnings per share was $0.42 this quarter which compares to non-GAAP EPS from continuing operations of $0.34 in last year's third quarter. Overall we're pleased with our team's ability to drive operational improvements resulting in improved gross profit margins, improved segment profit margins and controlled SG&A expenses resulting in growth in both earnings and EPS this quarter. The weaker macro environment has made sales growth a challenge which we expect to continue to the remainder of 2016 and into next fiscal year as well, but we know that the team is motivated and dedicated to achieving operational excellence in everything that we do and we know we have opportunities for continued profit improvement. Slide number 8 summarizes our quarterly cash generation. This quarter we finished with $40.3 million of cash from operating activities compared to $28.8 million in last year's third quarter. Looking at free cash flow, we finished this quarter at $36.8 million compared with $23.1 million in last year's third quarter. The chart in the upper left-hand corner of this slide provides more detail on cash generation. The bars represents cash flow from operation activities and illustrate how we realized improved cash flows over the last several quarters as we've moved beyond the period of elevated cash outflows from our restructuring programs and facility consolidation activities and into a period of increased focus, which is really helping in increased cash generation. We returned $10.2 million to our shareholders in the form of dividend this quarter, while repaying $13.3 million of debt. Looking forward, we expect cash flow to continue to be solid however due to tougher prior year comparables we do expect that our year-on-year free cash flow percentage growth will moderate in the fourth quarter. Our EBITDA trending and net debt trending are presented on Slide number 9. Our net debt to EBITDA was approximately 0.8 to 1 at the end of the quarter. Our total net debt position has been trending down since December 2012 and at April 30, 2016 it was $100.9 million compared to net debt of $167.9 million at the same time last year. Our balance sheet is strong which gives us the flexibility to fund future growth opportunities and return funds to our shareholders. Our disciplined and patient capital allocation approach remains unchanged. First, we use our cash to fund organic growth opportunities which includes funding, investments and new product development, digital enhancements, sales generating personnel capital expenditures and alike. Second, we're focused on returning cash to our shareholders in the form of dividends. Our streak of annual dividends, dividend increases has now reached 30 consecutive years. Third, we use our cash to improve shareholders returns through share repurchases. Share repurchases are executed in an opportunistic and patient manner, whereby we only repurchase shares when we see an opportunity to drive meaningful incremental shareholder value. Fourth and finally, we use our cash for acquisitions. As we've stated we do not expect acquisitions to be a significant use of cash in the near term. We believe that we can meaningful enhance shareholder value over the long-term by executing this prioritized and disciplined approach to capital allocation. Slide number 10 is our updated EPS guidance for fiscal 2016. We are increasing our full year guidance to $1.37 to $1.45 for the full fiscal year ending July 31. We expect that we will achieve this EPS guidance range on low single-digit organic revenue declines in both of our segments. Our revenue expectations are reflective of the current economic environment, which we believe provides near-term challenges in certain industrial end-markets and geographies including the US. In order to offset this weak sales outlook, we expect continued efficiency gains in our manufacturing facilities as well as in SG&A expenses. Other key assumptions in our guidance include CapEx which we believe will come in closer to $13 million versus our previous guidance range of $17 million to $20 million due to the timing of certain projects and we expect depreciation and amortization expense of approximately $33 million this fiscal year, which is also down slightly from our previous guidance range. Our tax rate is expected to be in the high 20% range. As is our historical practice, we are currently planning on providing formal fiscal 2017 guidance with our fourth quarter earnings release in September. However, we expect the current economic challenges to continue thus making organic growth difficult in fiscal 2017 and putting pressure on our ability to meaningfully improve earnings next year. These anticipated organic sales challenges as well as more clarity on our outlook and our priority, this will ultimately be incorporated into our full fiscal year 2017 guidance to be announced during our next earnings call in September. I'll now turn the call back to Michael to provide some color on our segments and some closing comments before turning the call over to Q&A. Michael?